Effect of somatostatin on duodenal glucose absorption in man

Abstract

Objective: The hyperglycemic hyperinsulinemic clamp technique using intraduodenally infused glucose is an attractive tool for studying postprandial glucose metabolism under strictly controlled conditions. Because it requires the use of somatostatin (SST), we examined, in this study, the effect of SST on intestinal glucose absorption. Context: Twenty-six normal volunteers were given a constant 3-h intraduodenal infusion of glucose (6 mg·kg -1·min-1) labeled with [2-3H]glucose for glucose absorption measurement. During glucose infusion, 19 subjects received iv SST at doses of 10-100 ng·kg-1·min-1 plus insulin and glucagon, and seven subjects were studied under control conditions. In the controls, glucose was absorbed at a rate that, after a 20-min lag period, equaled the infusion rate. Results: With all the doses of SST tested, absorption was considerably delayed but equaled the rate of infusion after 3 h. At that time, only 5 ± 2% of the total amount of infused glucose was unabsorbed in the control subjects vs. 36 ± 2% (P < 0.001) in the SST-infused subjects. In the latter, the intraluminal residue was almost totally absorbed within 40 min of the cessation of SST infusion. At the lowest dose of SST tested (10 ng·kg-1·min-1), suppression of insulin secretion was incomplete. Conclusion: These properties of SST hamper the use of intraduodenal hyperglycemic hyperinsulinemic clamps as a tool for exploring postprandial glucose metabolism. Copyright © 2005 by The Endocrine Society.